Literature DB >> 23647059

Importance of donor ethnicity/race matching in unrelated adult and cord blood allogeneic hematopoietic cell transplant.

Celalettin Ustun1, Veronika Bachanova, Ryan Shanley, Margaret L MacMillan, Navneet S Majhail, Mukta Arora, Claudio Brunstein, John E Wagner, Daniel J Weisdorf.   

Abstract

Donor race matching (both recipient and donor belonging to the same race) might be a factor in outcomes of donor allogeneic hematopoietic cell transplant (alloHCT). A total of 858 patients who underwent umbilical cord blood (UCB) (475 patients: 202 double UCB and 273 single UCB) or unrelated donor (URD) (383 patients) alloHCT between January 1995 and December 2010 were studied. Most patients were Caucasian (87%), followed by Asians (4%), African Americans (3%), Hispanics (3%), mixed race (3%) and American Indians (< 1%). Caucasians constituted 88% of the donor grafts; Caucasians were the most common race of the donor grafts among all races except for Asians. As a result, Caucasians were much more likely to have a race-matched donor than ethnic minorities (91% vs. 33%, p < 0.01). Donor race matching did not affect non-relapse mortality, relapse, acute or chronic graft-versus-host disease or overall survival. Acknowledging the limitations of this study (mainly, self-reported race information and small number of ethnic minorities), at present there are no data supporting that donor race should be considered a factor in donor selection.

Entities:  

Mesh:

Year:  2013        PMID: 23647059      PMCID: PMC4064795          DOI: 10.3109/10428194.2013.800200

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  26 in total

1.  Relationship of race/ethnicity and survival after single umbilical cord blood transplantation for adults and children with leukemia and myelodysplastic syndromes.

Authors:  Karen K Ballen; John P Klein; Tanya L Pedersen; Deepika Bhatla; Reggie Duerst; Joanne Kurtzberg; Hillard M Lazarus; Charles F LeMaistre; Phillip McCarthy; Paulette Mehta; Jeanne Palmer; Michelle Setterholm; John R Wingard; Steven Joffe; Susan K Parsons; Galen E Switzer; Stephanie J Lee; J Douglas Rizzo; Navneet S Majhail
Journal:  Biol Blood Marrow Transplant       Date:  2011-11-04       Impact factor: 5.742

2.  Reduced-intensity conditioning followed by related allografts in hematologic malignancies: long-term outcomes most successful in indolent and aggressive non-Hodgkin lymphomas.

Authors:  Erica D Warlick; Marcie Tomblyn; Qing Cao; Todd Defor; Bruce R Blazar; Margaret Macmillan; Michael Verneris; John Wagner; Kathryn Dusenbery; Mukta Aurora; Veronika Bachanova; Claudio Brunstein; Linda Burns; Sarah Cooley; Dan Kaufman; Navneet S Majhail; Brian McClune; Philip McGlave; Jeffrey Miller; Betul Oran; Arne Slungaard; Gregory Vercellotti; Daniel J Weisdorf
Journal:  Biol Blood Marrow Transplant       Date:  2010-11-01       Impact factor: 5.742

3.  Is race a risk factor for allogeneic marrow transplantation?

Authors:  H G Klingemann; H J Deeg; S Self; E D Thomas; R Storb
Journal:  Bone Marrow Transplant       Date:  1986-05       Impact factor: 5.483

Review 4.  Racial disparities in hematopoietic cell transplantation in the United States.

Authors:  N S Majhail; S Nayyar; M E Burton Santibañez; E A Murphy; E M Denzen
Journal:  Bone Marrow Transplant       Date:  2011-11-07       Impact factor: 5.483

Review 5.  Minor histocompatibility antigens--targets of graft versus leukemia responses.

Authors:  Stanley R Riddell; M Murata; S Bryant; E H Warren
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

6.  Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age.

Authors:  C Kollman; C W Howe; C Anasetti; J H Antin; S M Davies; A H Filipovich; J Hegland; N Kamani; N A Kernan; R King; V Ratanatharathorn; D Weisdorf; D L Confer
Journal:  Blood       Date:  2001-10-01       Impact factor: 22.113

7.  Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning.

Authors:  Juliet N Barker; Daniel J Weisdorf; Todd E DeFor; Bruce R Blazar; Jeffrey S Miller; John E Wagner
Journal:  Blood       Date:  2003-05-08       Impact factor: 22.113

8.  Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival.

Authors:  John E Wagner; Juliet N Barker; Todd E DeFor; K Scott Baker; Bruce R Blazar; Cindy Eide; Anne Goldman; John Kersey; William Krivit; Margaret L MacMillan; Paul J Orchard; Charles Peters; Daniel J Weisdorf; Norma K C Ramsay; Stella M Davies
Journal:  Blood       Date:  2002-09-01       Impact factor: 22.113

9.  Trends in survival rates after allogeneic hematopoietic stem-cell transplantation for acute and chronic leukemia by ethnicity in the United States and Canada.

Authors:  Derek S Serna; Stephanie J Lee; Mei-jie Zhang; k Scott Baker; Mary Eapen; Mary M Horowitz; John P Klein; J Douglas Rizzo; Fausto R Loberiza
Journal:  J Clin Oncol       Date:  2003-10-15       Impact factor: 44.544

10.  Factors predicting single-unit predominance after double umbilical cord blood transplantation.

Authors:  P Ramirez; J E Wagner; T E DeFor; B R Blazar; M R Verneris; J S Miller; D H McKenna; D J Weisdorf; P B McGlave; C G Brunstein
Journal:  Bone Marrow Transplant       Date:  2011-09-26       Impact factor: 5.483

View more
  9 in total

1.  Investigating the Association of Genetic Admixture and Donor/Recipient Genetic Disparity with Transplant Outcomes.

Authors:  Abeer Madbouly; Tao Wang; Michael Haagenson; Vanja Paunic; Cynthia Vierra-Green; Katharina Fleischhauer; Katharine C Hsu; Michael R Verneris; Navneet S Majhail; Stephanie J Lee; Stephen R Spellman; Martin Maiers
Journal:  Biol Blood Marrow Transplant       Date:  2017-03-02       Impact factor: 5.742

2.  Cord blood unit factors influencing transplant outcomes from the Asian multiethnic Singapore Cord Blood Bank.

Authors:  S-Y Ong; C Phipps; P Chu; A Prasath; A Y L Ho; S J Sobak; W Hwang
Journal:  Bone Marrow Transplant       Date:  2015-06-08       Impact factor: 5.483

3.  Predictive value of disease risk comorbidity index for overall survival after allogeneic hematopoietic transplantation.

Authors:  Nelli Bejanyan; Claudio G Brunstein; Qing Cao; Aleksandr Lazaryan; Celalettin Ustun; Erica D Warlick; Mukta Arora; John E Wagner; Daniel J Weisdorf
Journal:  Blood Adv       Date:  2019-02-12

4.  Monosomal karyotype at the time of diagnosis or transplantation predicts outcomes of allogeneic hematopoietic cell transplantation in myelodysplastic syndrome.

Authors:  Celalettin Ustun; Bryan J Trottier; Zohar Sachs; Todd E DeFor; Leyla Shune; Elizabeth L Courville; Shernan G Holtan; Michelle Dolan; Daniel J Weisdorf; Erica D Warlick
Journal:  Biol Blood Marrow Transplant       Date:  2015-01-22       Impact factor: 5.742

5.  Cord blood collection and banking from a population with highly diverse geographic origins increase HLA diversity in the registry and do not lower the proportion of validated cord blood units: experience of the Marseille Cord Blood Bank.

Authors:  C Bordoni; J Magalon; C Gilbertas; M Gamerre; P Le Coz; M Berthomieu; C Chabannon; J Di Cristofaro; C Picard
Journal:  Bone Marrow Transplant       Date:  2015-01-26       Impact factor: 5.483

6.  Hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: risk factors, graft source and survival.

Authors:  L E Lunde; S Dasaraju; Q Cao; C S Cohn; M Reding; N Bejanyan; B Trottier; J Rogosheske; C Brunstein; E Warlick; J A H Young; D J Weisdorf; C Ustun
Journal:  Bone Marrow Transplant       Date:  2015-07-13       Impact factor: 5.483

7.  Reduction in Mortality after Umbilical Cord Blood Transplantation in Children Over a 20-Year Period (1995-2014).

Authors:  Lisa P Spees; Paul L Martin; Joanne Kurtzberg; Andre Stokhuyzen; Lauren McGill; Vinod K Prasad; Timothy A Driscoll; Suhag H Parikh; Kristin M Page; Richard Vinesett; Christopher Severyn; Anthony D Sung; Alan D Proia; Kirsten Jenkins; Mehreen Arshad; William J Steinbach; Patrick C Seed; Matthew S Kelly
Journal:  Biol Blood Marrow Transplant       Date:  2018-11-24       Impact factor: 5.742

8.  Advance care planning among hematopoietic cell transplant patients and bereaved caregivers.

Authors:  E T Loggers; S Lee; K Chilson; A L Back; S Block; F R Loberiza
Journal:  Bone Marrow Transplant       Date:  2014-07-28       Impact factor: 5.483

Review 9.  Milestones of Hematopoietic Stem Cell Transplantation - From First Human Studies to Current Developments.

Authors:  Mateja Kralj Juric; Sakhila Ghimire; Justyna Ogonek; Eva M Weissinger; Ernst Holler; Jon J van Rood; Machteld Oudshoorn; Anne Dickinson; Hildegard T Greinix
Journal:  Front Immunol       Date:  2016-11-09       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.